Literature DB >> 16297194

Reduced expression of interleukin-2 decreases the frequency of alopecia areata onset in C3H/HeJ mice.

Pia Freyschmidt-Paul1, Kevin J McElwee, Rolf Hoffmann, John P Sundberg, Sabine Kissling, Susanne Hummel, Mario Vitacolonna, Annette Kopp-Schneider, Margot Zöller.   

Abstract

Alopecia areata (AA) is an autoimmune hair loss disease, that can be transferred between C3H/HeJ mice by skin grafting. We explored whether AA susceptibility is influenced by the availability of interleukin (IL)-2, a cytokine with leukocyte activating and regulatory properties. Mice heterozygous for a targeted deletion of IL-2 from the histocompatible C3.129P2(B6)-Il2(tm1Hor) substrain, that produce reduced levels of IL-2, were examined for AA development after grafting skin from AA-affected C3H/HeJ mice. After grafting, nine of 19 (47%) heterozygous IL-2+/-versus 16 of 18 (88%) IL-2+/+ wild-type littermates developed AA. Although dense follicular leukocyte infiltrates were apparent in AA affected wild-type mice, AA-developing IL-2+/- littermates had a reduced leukocyte infiltration, and AA-resistant IL-2+/- mice had no inflammation. Lymph node cell analysis revealed a reduction in leukocyte activation markers in AA-developing IL-2+/- mice. IL-2+/- mice presented with low level expression of cytokines (IL-4, IL-10, interferon-gamma, transforming growth factor-beta), upregulation of tumor necrosis factor receptors, and increased leukocyte apoptosis susceptibility independent of AA expression. In the skin, CD4+ cells and monocytes were reduced; activation markers were not upregulated and very few CD44v3+ or CD44v10+ leukocytes were recovered. Taken together, our data suggest that AA resistance of IL-2+/- mice is because of the failure of activated leukocyte recruitment, thus pointing toward an involvement of IL-2 in AA pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297194     DOI: 10.1111/j.0022-202X.2005.23888.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

Review 1.  Lymphocytes, neuropeptides, and genes involved in alopecia areata.

Authors:  Amos Gilhar; Ralf Paus; Richard S Kalish
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

2.  Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.

Authors:  Luzhou Xing; Zhenpeng Dai; Ali Jabbari; Jane E Cerise; Claire A Higgins; Weijuan Gong; Annemieke de Jong; Sivan Harel; Gina M DeStefano; Lisa Rothman; Pallavi Singh; Lynn Petukhova; Julian Mackay-Wiggan; Angela M Christiano; Raphael Clynes
Journal:  Nat Med       Date:  2014-08-17       Impact factor: 53.440

Review 3.  The current state of knowledge of the immune ecosystem in alopecia areata.

Authors:  Samuel J Connell; Ali Jabbari
Journal:  Autoimmun Rev       Date:  2022-02-10       Impact factor: 17.390

4.  Endogenous retinoids in the pathogenesis of alopecia areata.

Authors:  F Jason Duncan; Kathleen A Silva; Charles J Johnson; Benjamin L King; Jin P Szatkiewicz; Sonya P Kamdar; David E Ong; Joseph L Napoli; Jinshan Wang; Lloyd E King; David A Whiting; Kevin J McElwee; John P Sundberg; Helen B Everts
Journal:  J Invest Dermatol       Date:  2012-09-27       Impact factor: 8.551

Review 5.  An overview of JAK/STAT pathways and JAK inhibition in alopecia areata.

Authors:  Maddison Lensing; Ali Jabbari
Journal:  Front Immunol       Date:  2022-08-30       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.